Literature DB >> 4716845

Striatonigral degeneration. Response to levodopa therapy with pathological and neurochemical correlation.

J A Sharpe, N B Rewcastle, K G Lloyd, O Hornykiewicz, M Hill, R R Tasker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4716845     DOI： 10.1016/0022-510x(73)90091-9

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN： 0022-510X            Impact factor:   3.181


× No keyword cloud information.
  6 in total

1.  The dopaminergic response in multiple system atrophy.

Authors:  A J Hughes; C Colosimo; B Kleedorfer; S E Daniel; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-11       Impact factor: 10.154

Review 2.  Parkinson's disease and levodopa. A five-year follow-up and review.

Authors:  C H Markham; L J Treciokas; S G Diamond
Journal:  West J Med       Date:  1974-09

3.  Dopa decarboxylase activity of the living human brain.

Authors:  A Gjedde; J Reith; S Dyve; G Léger; M Guttman; M Diksic; A Evans; H Kuwabara
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

4.  Calcineurin immunoreactivity in striatonigral degeneration.

Authors:  S Goto; A Hirano; R R Rojas-Corona
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

5.  The use of lisuride in the treatment of multiple system atrophy with autonomic failure (Shy-Drager syndrome).

Authors:  A J Lees; R Bannister
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-04       Impact factor: 10.154

6.  Adult human olfactory epithelial-derived progenitors: a potential autologous source for cell-based treatment for Parkinson's disease.

Authors:  Meng Wang; Chengliang Lu; Fred Roisen
Journal:  Stem Cells Transl Med       Date:  2012-06-01       Impact factor: 6.940
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.